Throughout IU School of Medicine, we’ve made recruiting and retaining talent – students, faculty and staff –a top priority. And it’s paying off.
Applications to the School of Medicine have nearly doubled in the last five years. Not only was the class arriving in fall 2016 the most academically accomplished, it was also the school’s most diverse class ever, with 23 percent black/African-American or Hispanic/Latino students.
Over the past four years, we recruited ten new department chairs, three regional campus deans, and three new center and institute directors. Over the past year alone we recruited a number of new leaders, including Dr. David Wallace from Duke, who will serve as Chair of the Department of Ophthalmology, Dr. Michael Weiss, who will be Chair of the Department of Biochemistry and Molecular Biology and Head of Chemical Biology for the Precision Health Initiative, Dr. Kun Huang, head of Data Science for the Precision Health Initiative and Dr. Peter Embi from Ohio State as the Regenstrief Institute CEO. In addition, we made several promotions, including Dr. Emily Walvoord as Associate Dean for Student Affairs; Dr. Peter Duong as Associate Dean for Admissions and Financial Aid; Dr. Megan Palmer, Associate Dean and Dr. Matt Allen, Assistant Dean, both for Faculty Development in OFAPD; and Dr. Naga Chalasani, Associate Dean of Clinical Research. Additionally, two of our esteemed colleagues – Dr. Anantha Shekhar and Dr. Tatiana Foroud – were named Distinguished Professors in the School of Medicine.
To learn more about the strategic planning priocess now underway to to harness this momentum and continue building on the quality improvements, visit the IU School of Medicine Strategic Planning page. To get involved and help the school evaulate where we stand and how to further improve on specific priority areas, please take a short survey.
